2024-02-21 19:09 | CC:RVX | Resverlogix Corp | 0.065 | News Release200 | Resverlogix director Lu resigns |
2024-01-11 10:57 | CC:RVX | Resverlogix Corp | 0.065 | News Release200 | Resverlogix brags of apabetalone article publication |
2023-11-09 19:19 | CC:RVX | Resverlogix Corp | 0.07 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-09 19:14 | CC:RVX | Resverlogix Corp | 0.07 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-10-04 12:51 | CC:RVX | Resverlogix Corp | 0.07 | News Release200 | Resverlogix publishes apabetalone article in Biomedicines |
2023-08-29 13:12 | CC:RVX | Resverlogix Corp | 0.08 | News Release200 | Resverlogix cheers cardiovascular treatment guidelines |
2023-08-11 19:02 | CC:RVX | Resverlogix Corp | 0.095 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-06-29 18:10 | CC:RVX | Resverlogix Corp | 0.085 | News Release200 | Resverlogix to reduce warrant exercise price |
2023-06-20 18:18 | CC:RVX | Resverlogix Corp | 0.10 | News Release200 | Resverlogix shareholders elect five directors at AGM |
2023-06-12 10:25 | CC:RVX | Resverlogix Corp | 0.105 | News Release200 | Resverlogix apabetalone data published in Biomedicines |
2023-05-17 12:04 | CC:RVX | Resverlogix Corp | 0.13 | Warrants Expire110 | Resverlogix warrants to expire June 7 |
2023-05-11 18:11 | CC:RVX | Resverlogix Corp | 0.14 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-11 18:11 | CC:RVX | Resverlogix Corp | 0.14 | SEDAR MD & A815 | SEDAR MD & A |
2023-03-31 19:28 | CC:RVX | Resverlogix Corp | 0.145 | SEDAR MD & A815 | SEDAR MD & A |
2023-03-31 19:26 | CC:RVX | Resverlogix Corp | 0.145 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-03-31 19:20 | CC:RVX | Resverlogix Corp | 0.145 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |